Start Date
January 15, 2021
Primary Completion Date
February 14, 2022
Study Completion Date
June 14, 2022
Pendulum Glucose Control formulation for T2D
"All bacteria contained in the study product formulation are commensal organisms that have been repeatedly documented to inhabit the human GI tract under normal circumstances. Pendulum's Glucose Control Formulation consists of five human commensal microbial strains including butyrate producing and mucin-degrading strains. The organisms were grown under controlled conditions consistent with Good Manufacturing Practices (GMP) and employ no animal-derived products. All ingredients utilized during manufacturing were food grade and qualified as generally recognized as safe (GRAS).~The product is provided as acid-resistant capsules in bottles that are to be stored refrigerated at 4℃."
USC Westside Center for Diabetes, Los Angeles
Collaborators (1)
Pendulum Therapeutics
INDUSTRY
University of Southern California
OTHER